Progress Against Prostate Cancer. 1970–1979 Progress Against Prostate Cancer 1970–1979 Early 1970s: Radioactive ''seeds'' proven effective for prostate.
Progress Against Lymphoma. 1970–1979 Progress Against Lymphoma 1970–1979 1974: FDA approves doxorubicin, a vital part of combination chemotherapy.
Plant-produced subviral HBV particles as carriers for antigen protein epitopes for the purpose of vaccines
Non-Small-Cell Lung Cancer Leading cause of cancer-related mortality in the US Current Therapies: –“ Despite great efforts, only minor gains” Traynor.
UNLOCKING THE FULL POTENTIAL OF ORAL VACCINES A Non-Replicating Ad5 Vaccine for the Treatment of HSV-2 Infection Wendy Peters, PhD | Associate Director.
THERAPEUTIC CANCER VACCINES Cancer Immunology and Immunotherapy Center St. Savas Cancer Hospital.
Towards a therapeutic vaccine to reduce HIV reservoir, both neutralizing HIV and inhibiting effector T cells depletion Pr. Patrice DEBRE Laboratoire Immunité.
New Prevention Technologies
